IPP Bureau
Govt. appoints Rajeev Raghuvanshi new DGCI
By IPP Bureau - February 24, 2023
MEI Pharma and Infinity Pharmaceuticals inks merger agreement to advance three promising clinical oncology candidates
By IPP Bureau - February 24, 2023
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
Briefs: Alkem and Krsnaa Diagnostics
By IPP Bureau - February 24, 2023
Alkem has submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines.
National Health Authority facilitating Quick OPD registration in 365 hospitals
By IPP Bureau - February 24, 2023
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
Venus Remedies gets marketing approval for cancer drugs from Uzbekistan, Palestine
By IPP Bureau - February 23, 2023
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
Moderna and Merck announce investigational personalized cancer vaccine mRNA-4157/V940
By IPP Bureau - February 23, 2023
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
AIIA Goa conducts induction programme for first batch of BAMS student
By IPP Bureau - February 23, 2023
Ayurveda is one of the most advanced sciences of its times
Research underscores Beyfortus’ potential to prevent RSV disease in infants
By IPP Bureau - February 23, 2023
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
Aji Bio-Pharma develops highly functional ancestral RNA ligase
By IPP Bureau - February 23, 2023
This artificial RNA ligase has higher thermostability than natural RNA ligase
Thyrocare adopts SigTuple’s AI100 to make quality diagnostics accessible
By IPP Bureau - February 22, 2023
In a bid to better leverage its clinical expertise and drive quality reporting across its centres, Thyrocare has added SigTuple’s AI100 to automate the microscopic review in its laboratories
Genomics, big data among key themes driving M&A activity in medical devices, says GlobalData
By IPP Bureau - February 22, 2023
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
USFDA accepts biologics license application for Pfizer’s respiratory syncytial virus maternal vaccine candidate for priority review
By IPP Bureau - February 22, 2023
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
Merck updates on Phase 3 MOVe-AHEAD trial evaluating Lagevrio
By IPP Bureau - February 22, 2023
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
Mandaviya focuses on high value pharmaceuticals and high-end medical devices to reduce the import dependency
By IPP Bureau - February 22, 2023
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Redcliffe Labs launches BD MAX MDR TB test for MDR-TB in a Single test
By IPP Bureau - February 21, 2023
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
